Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Sanjivani Paranteral Ltd.

Sanjivani Paranteral

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
25 05 2021 Quarterly Results & Audited Results
25 06 2021 Preferential Issue of shares
26 07 2021 Quarterly Results
12 11 2021 Quarterly Results
14 02 2022 Quarterly Results
17 05 2022 Audited Results
08 08 2022 Quarterly Results
14 11 2022 Quarterly Results
14 02 2023 Quarterly Results
06 05 2023 Audited Results
24 07 2023 Quarterly Results
18 10 2023 Quarterly Results
25 12 2023 Preferential Issue of shares & Issue Of Warrants
05 02 2024 Quarterly Results
08 04 2024 Inter alia, to consider and transact the following businesses: 1. To consider the proposal for Change in Designation of Mr. Srivardhan Ashwani Khemka (DIN: 08942106), from Non-Executive Director to Executive Director with effect from 08th April, 2024; 2. To take a note of Resignation of Mr. Shrenikkumar Parasmalji Solanki, Independent Director of the Company with effect from 08th April, 2024; 3. Appointment of Mr. Abhay Shah (DIN: 10562812) as an Additional Director of the company under Independent Category with effect from Monday, 08th April, 2024, till ensuing General Meeting. 4. Any other matter with the permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
28 10 2024 Quarterly Results
10 02 2025 Quarterly Results
27 05 2025 Dividend & Audited Results
12 08 2025 Quarterly Results
14 11 2025 Quarterly Results
13 02 2026 Quarterly Results

News

08-SEP-2025

Sanjivani Paranteral’s arm starts commercial production at IV Fluid infusion plant in Pune

The facility has been designed with a dual focus on efficiency and sustainability

03:38 PM
28-FEB-2024

Sanjivani Paranteral incorporates subsidiary company

The said subsidiary has been incorporated for manufacturing of Pharmaceuticals formulations and medical devices including IV Fluid and IV Sets

06:33 PM
02-AUG-2023

Sanjivani Paranteral inks pact with Hindustan Antibiotics

The agreement is backed by confirmed purchase commitment from Hindustan Antibiotics

03:15 PM
09-MAY-2023

Sanjivani Paranteral enters into partnership with Aievia Helathcare

The partnership aims to launch a new project that aims to cater the requirements of the Pharma markets of European Union

03:49 PM
Enrich money logo